Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2017 Feb 24;15(1):48.
doi: 10.1186/s12967-017-1149-0.

Comparative analysis of curative effect of bone marrow mesenchymal stem cell and bone marrow mononuclear cell transplantation for spastic cerebral palsy

Xuebin Liu  1 , Xiaojun Fu  1 , Guanghui Dai  1 , Xiaodong Wang  1 , Zan Zhang  1 , Hongbin Cheng  1 , Pei Zheng  1 , Yihua An  2
Affiliations
Randomized Controlled Trial

Comparative analysis of curative effect of bone marrow mesenchymal stem cell and bone marrow mononuclear cell transplantation for spastic cerebral palsy

Xuebin Liu et al. J Transl Med. .

Abstract

Background: Bone marrow mesenchymal stem cells (BMMSCs) and bone marrow mononuclear cells (BMMNCs) are both used to treat spastic cerebral palsy. However, the differences in therapeutic effect remain unknown.

Methods: A total of 105 patients with spastic cerebral palsy were enrolled and randomly assigned to three groups: the BMMSC group, the BMMNC group and the control group. Patients in both transplantation groups received four intrathecal cell injections. Patients in the control group received Bobath therapy. The gross motor function measure (GMFM) and the fine motor function measure (FMFM) were used to evaluate the therapeutic efficacy before transplantation and 3, 6, and 12 months after transplantation.

Results: Three months after cell transplantation, scores in the A dimension of GMFM and the A and C dimensions of FMFM scores in the BMMSC group are all higher than those of the BMMNC and the control groups (P < 0.05). Six months after cell transplantation, scores in the A, B dimensions of GMFM and the A, B, C, D, and E dimensions of FMFM scores in the BMMSC group are higher than those of the BMMNC and the control groups (P < 0.05). Twelve months after cell transplantation, scores in the A, B, and C dimensions of GMFM and the A, B, C, D, and E dimensions of FMFM scores in the BMMSC group are all higher than those of the BMMNC and the control groups (P < 0.05). No obvious adverse effects were investigated during follow-up.

Conclusions: BMMSC transplantation for the treatment of cerebral palsy is safe and feasible, and can improve gross motor and fine motor function significantly. In addition, compared with BMMNC, the motor function of children improved significantly in terms of gross motor and fine motor functions.

Keywords: Bone marrow mesenchymal stem cells; Bone marrow mononuclear cells; Spastic cerebral palsy.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Experimental design
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Shevell MI, Majnemer A, Morin I. Etiologic yield of spastic cerebral palsy: a contemporary case series. Pediatr Neurol. 2003;28(5):352–359. doi: 10.1016/S0887-8994(03)00006-7. - DOI - PubMed
    1. Paneth N, Hong T, Korzeniewski S. The descriptive epidemiology of spastic cerebral palsy. Clin Perinatol. 2006;33(2):251–267. doi: 10.1016/j.clp.2006.03.011. - DOI - PubMed
    1. Holt RL, Mikati MA. Care for child development: basic science rationale and effects of interventions. Pediatr Neurol. 2011;44(4):239–253. doi: 10.1016/j.pediatrneurol.2010.11.009. - DOI - PubMed
    1. Sharma A, Sane H, Gokulchandran N, Kulkarni P, Gandhi S, Sundaram J, Paranjape A, Shetty A, Bhagwanani K, Biju H, et al. A clinical study of autologous bone marrow mononuclear cells for spastic cerebral palsy patients: a new frontier. Stem Cells Int. 2015;2015:905874. doi: 10.1155/2015/905874. - DOI - PMC - PubMed
    1. Jin JL, Liu Z, Lu ZJ, Guan DN, Wang C, Chen ZB, Zhang J, Zhang WY, Wu JY, Xu Y. Safety and efficacy of umbilical cord mesenchymal stem cell therapy in hereditary spinocerebellar ataxia. Curr Neurovasc Res. 2013;10(1):11–20. doi: 10.2174/156720213804805936. - DOI - PubMed

Publication types